Boron uptake in normal melanocytes and melanoma cells and boron biodistribution study in mice bearing B16F10 melanoma for boron neutron capture therapy

[1]  D. Maria,et al.  Boron neutron capture therapy induces cell cycle arrest and DNA fragmentation in murine melanoma cells. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[2]  D. Maria,et al.  Antitumor potential induction and free radicals production in melanoma cells by Boron Neutron Capture Therapy. , 2011, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[3]  Junnian Zheng,et al.  Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis. , 2010, Cancer letters.

[4]  L. Tanoue.  Cancer Statistics, 2009 , 2010 .

[5]  A. Scherag,et al.  Biodistribution of 10B for Boron Neutron Capture Therapy (BNCT) in a Mouse Model after Injection of Sodium Mercaptoundecahydro-closo-dodecaborate and l-para-Boronophenylalanine , 2009, Radiation research.

[6]  G. S. Santa Cruz,et al.  BNCT for skin melanoma in extremities: updated Argentine clinical results. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[7]  H. Ichikawa,et al.  Biodistribution of BPA and BSH after single, repeated and simultaneous administrations for neutron-capture therapy of cancer. , 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[8]  H. Arlinghaus,et al.  Boron analysis and boron imaging in biological materials for Boron Neutron Capture Therapy (BNCT). , 2008, Critical reviews in oncology/hematology.

[9]  R. Mortara,et al.  A cell surface 230 kDa protein from murine melanoma involved with tumor malignancy. , 2008, Cancer letters.

[10]  A. Matsumura,et al.  Boron neutron capture therapy for glioblastoma. , 2008, Cancer letters.

[11]  M. Itoiz,et al.  Boron neutron capture therapy (BNCT) for the treatment of spontaneous nasal planum squamous cell carcinoma in felines , 2008, Radiation and environmental biophysics.

[12]  Y. Yura,et al.  Effect of neutron capture therapy on the cell cycle of human squamous cell carcinoma cells , 2008, International journal of radiation biology.

[13]  L. Collette,et al.  Uptake of two 10B‐compounds in liver metastases of colorectal adenocarcinoma for extracorporeal irradiation with boron neutron capture therapy (EORTC Trial 11001) , 2007, International journal of cancer.

[14]  E. Gautier,et al.  Assessment of chemical purity of 10B-enriched p-boronophenylalanine by high-performance liquid chromatography coupled on-line with inductively coupled plasma optical emission spectrometry , 2007, Analytical and bioanalytical chemistry.

[15]  K. W. Park,et al.  Determination of boron in a black mouse by prompt gamma activation analysis , 2007 .

[16]  R. Barth.  A critical assessment of boron neutron capture therapy: an overview , 2003, Journal of Neuro-Oncology.

[17]  S. Lowe,et al.  Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. , 2005, Cancer research.

[18]  M. Pisarev,et al.  Biodistribution of boron compounds in an animal model of human undifferentiated thyroid cancer for boron neutron capture therapy. , 2005, Molecular pharmaceutics.

[19]  K. Ono,et al.  Biodistribution of 10B in a rat liver tumor model following intra-arterial administration of sodium borocaptate (BSH)/degradable starch microspheres (DSM) emulsion. , 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

[20]  J. Espín,et al.  Grape polyphenol resveratrol and the related molecule 4-hydroxystilbene induce growth inhibition, apoptosis, S-phase arrest, and upregulation of cyclins A, E, and B1 in human SK-Mel-28 melanoma cells. , 2003, Journal of agricultural and food chemistry.

[21]  E. Kreimann,et al.  Biodistribution of a carborane-containing porphyrin as a targeting agent for Boron Neutron Capture Therapy of oral cancer in the hamster cheek pouch. , 2003, Archives of oral biology.

[22]  Hongyan Liu,et al.  Boswellic acid acetate induces differentiation and apoptosis in highly metastatic melanoma and fibrosarcoma cells. , 2003, Cancer detection and prevention.

[23]  Y. Kanai,et al.  Transport of amino acid-related compounds mediated by L-type amino acid transporter 1 (LAT1): insights into the mechanisms of substrate recognition. , 2002, Molecular pharmacology.

[24]  T. Probst.  Methods for boron analysis in boron neutron capture therapy (BNCT). A review , 1999 .

[25]  J. Coderre,et al.  The radiation biology of boron neutron capture therapy. , 1999, Radiation research.

[26]  R. Barth,et al.  The Chemistry of Neutron Capture Therapy. , 1998, Chemical reviews.

[27]  H. B. Liu,et al.  Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex. , 1994, International journal of radiation oncology, biology, physics.

[28]  H. Fukuda,et al.  Boron neutron capture therapy of malignant melanoma using 10B-paraboronophenylalanine with special reference to evaluation of radiation dose and damage to the normal skin. , 1994, Radiation research.

[29]  M. Moeschberger,et al.  A nude rat model for neutron capture therapy of human intracerebral melanoma. , 1994, International journal of radiation oncology, biology, physics.

[30]  W. Sauerwein.  Principles and history of neutron capture therapy. , 1993, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[31]  D. Slatkin,et al.  Boron neutron capture therapy of a murine melanoma with p-boronophenylalanine: dose-response analysis using a morbidity index. , 1991, Radiation research.

[32]  D. Joel,et al.  Selective delivery of boron by the melanin precursor analogue p-boronophenylalanine to tumors other than melanoma. , 1990, Cancer research.

[33]  T. Mosmann.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[34]  F. Meyskens.  Modulation of abnormal growth by retinoids: a clinical perspective of the biological phenomenon. , 1981, Life sciences.

[35]  I. Ikeuchi,et al.  A colorimetric determination of boron in biological materials. , 1978, Chemical & pharmaceutical bulletin.

[36]  I. Fidler.  Biological behavior of malignant melanoma cells correlated to their survival in vivo. , 1975, Cancer research.